Intrinsiqq
Medpace Holdings Inc. logo

Medpace Holdings Inc. (MEDP) Insider Trading

Last 12 months

Insiders sold $467M and bought nothing on the open market.

3% of the selling was scheduled in advance under 10b5-1 plans. CEO August J. Troendle sold $62M on Nov 25, 2025 outside a plan. The last open-market buy by an executive or director was in Feb 2025.

Net open-market
−$467M
0 buys · 39 sales
Under a 10b5-1 plan
3%
of the value sold
Insiders who bought / sold
0 / 9
executives and directors
Last open-market buy
Feb 2025
Feb 27, 2025

Get an email when MEDP's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

  • Sep 29 – 30No plan
    August J. Troendle
    President & CEO · sold 48,667 at avg $623.03
    $30.3M
    1.0% of stake
  • Sep 25 – 28No plan
    August J. Troendle
    President & CEO · sold 2,564 at avg $620.10
    $1.59M
    <0.1% of stake
  • Sep 23 – 24No plan
    August J. Troendle
    President & CEO · sold 43,916 at avg $624.01
    $27.4M
    0.9% of stake
  • Sep 21 – 22No plan
    August J. Troendle
    President & CEO · sold 70,901 at avg $626.62
    $44.4M
    1.4% of stake
  • Sep 17No plan
    August J. Troendle
    President & CEO · sold 10,880 at $620.40
    $6.75M
    0.2% of stake
  • Sep 15 – 16No plan
    August J. Troendle
    President & CEO · sold 24,741 at avg $621.00
    $15.4M
    0.5% of stake
  • Aug 27No plan
    August J. Troendle
    President & CEO · sold 650 at $620.27
    $403k
    <0.1% of stake
  • Aug 26No plan
    Robert O. Kraft
    Director · sold 3,858 at $617.81
    $2.38M
    80% of stake
  • Aug 25 – 26No plan
    August J. Troendle
    President & CEO · sold 4,673 at avg $620.08
    $2.9M
    <0.1% of stake
  • Aug 21 – 24No plan
    August J. Troendle
    President & CEO · sold 15,978 at avg $623.93
    $9.97M
    0.3% of stake
  • Aug 20No plan
    Kevin M. Brady
    CFO & Treasurer · sold 3,400 at $625.24
    $2.13M
    21% of stake
  • Aug 19 – 20No plan
    August J. Troendle
    President & CEO · sold 42,783 at avg $614.30
    $26.3M
    0.8% of stake
  • Aug 19No plan
    Brian T Carley
    Director · sold 5,000 at $608.63
    $3.04M
    15% of stake
  • Aug 19No plan
    Fred B Davenport Jr
    Director · sold 7,283 at $606.15
    $4.41M
    56% of stake
  • Aug 12 – 13No plan
    August J. Troendle
    President & CEO · sold 11,824 at avg $601.49
    $7.11M
    0.2% of stake
  • Aug 11No plan
    Cornelius P. McCarthy III
    Director · sold 1,140 at $605.37
    $690k
    8.5% of stake
  • Aug 10 – 11No plan
    August J. Troendle
    President & CEO · sold 23,144 at avg $604.25
    $14M
    0.4% of stake
  • Aug 7No plan
    Cornelius P. McCarthy III
    Director · sold 795 at $585.07
    $465k
    5.6% of stake
  • Jul 28No plan
    Susan E Burwig
    Exec. VP, Operations · sold 7,500 at $600.00
    $4.5M
    11% of stake
  • Jul 27 – 28No plan
    August J. Troendle
    President & CEO · sold 7,238 at avg $600.44
    $4.35M
    0.1% of stake
  • May 28No plan
    Stephen P Ewald
    General Counsel & Corp. Secy. · sold 16,349 at $450.00
    $7.36M
    45% of stake
  • Mar 17No plan
    Jesse J Geiger
    President · sold 31,707 at $455.30
    $14.4M
    68% of stake
  • Dec 3, 2025No plan
    August J. Troendle
    CEO · sold 668 at $590.69
    $395k
    <0.1% of stake
  • Dec 1, 2025 – Dec 2, 2025No plan
    August J. Troendle
    CEO · sold 28,876 at avg $592.70
    $17.1M
    0.5% of stake
  • Nov 26, 2025 – Nov 28, 2025No plan
    August J. Troendle
    CEO · sold 56,482 at avg $603.28
    $34.1M
    1.0% of stake
  • Nov 24, 2025 – Nov 25, 2025No plan
    August J. Troendle
    CEO · sold 101,417 at avg $611.02
    $62M
    1.8% of stake
  • Nov 24, 2025No plan
    Susan E Burwig
    Exec. VP, Operations · sold 20,000 at $609.15
    $12.2M
    42% of stake
  • Nov 21, 2025No plan
    Kevin M. Brady
    CFO & Treasurer · sold 3,000 at $590.35
    $1.77M
    34% of stake
  • Nov 20, 2025 – Nov 21, 2025No plan
    August J. Troendle
    CEO · sold 28,688 at avg $593.68
    $17M
    0.5% of stake
  • Nov 18, 2025 – Nov 19, 2025No plan
    August J. Troendle
    CEO · sold 31,053 at avg $591.79
    $18.4M
    0.6% of stake
  • Nov 14, 2025 – Nov 17, 2025No plan
    August J. Troendle
    CEO · sold 20,794 at avg $594.02
    $12.4M
    0.4% of stake
  • Nov 14, 2025No plan
    Robert O. Kraft
    Director · sold 6,472 at $591.85
    $3.83M
    89% of stake
  • Nov 12, 2025 – Nov 13, 2025No plan
    August J. Troendle
    CEO · sold 10,440 at avg $602.32
    $6.29M
    0.2% of stake
  • Nov 11, 2025No plan
    Susan E Burwig
    Exec. VP, Operations · sold 18,000 at $605.00
    $10.9M
    27% of stake
  • Nov 5, 202510b5-1 plan
    Jesse J Geiger
    President · sold 21,503 at $595.66
    $12.8M
    59% of stake
  • Oct 30, 2025No plan
    Fred B Davenport Jr
    Director · sold 5,972 at $581.88
    $3.47M
    52% of stake
  • Oct 27, 2025 – Oct 29, 2025No plan
    Jesse J Geiger
    President · sold 23,028 at avg $602.00
    $13.9M
    39% of stake
  • Oct 27, 2025No plan
    Susan E Burwig
    Exec. VP, Operations · sold 2,000 at $605.01
    $1.21M
    3.0% of stake
  • Oct 27, 2025No plan
    Stephen P Ewald
    General Counsel & Corp. Secy. · sold 15,230 at $598.85
    $9.12M
    53% of stake
  • Sep 3, 2025No plan
    Susan E Burwig
    Exec. VP, Operations · sold 10,000 at $480.00
    $4.8M
    15% of stake
How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch MEDP, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Related stocks: Services-Commercial Physical & Biological Research

Spot a number that looks wrong? Check it in MEDP's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing MEDP

Create a free account and get 14 days of Premium: every stock and every tool.

  • Unlimited stocks
  • Stock screener
  • Portfolio tracker
  • Editable DCF
  • Compare side by side
  • Unlimited alerts

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

SectorsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.